P30 Semi-Markov Model (sMM) Versus Trial-Level Surrogacy to Predict Overall Survival (OS) for Adjuvant Treatment of Muscle-Invasive Urothelial Carcinoma (MIUC) with Chemotherapy
Jun 1, 2024, 00:00
10.1016/j.jval.2024.03.056
https://www.valueinhealthjournal.com/article/S1098-3015(24)00171-2/fulltext
Title :
P30 Semi-Markov Model (sMM) Versus Trial-Level Surrogacy to Predict Overall Survival (OS) for Adjuvant Treatment of Muscle-Invasive Urothelial Carcinoma (MIUC) with Chemotherapy
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(24)00171-2&doi=10.1016/j.jval.2024.03.056
First page :
Section Title :
Open access? :
No
Section Order :
11714